Largest biotechnology: pharmaceutical preparations companies
Every US-listed biotechnology: pharmaceutical preparations company we cover — 501 of them — ranked by market capitalisation, with revenue and earnings taken from their SEC filings.
Combined market cap
$5.087 T
5.1% of all US-listed value
Companies
501
Ranked #5 of 152 industries
Average
$10.153 B
Mean market cap per company
| # | Name | Market cap | Close | Session | Country |
|---|---|---|---|---|---|
| 1 | Eli Lilly & CoLLY | $1.12T | $1,185.71 | -0.52% | United States |
| 2 | Johnson & JohnsonJNJ | $624.7B | $259.24 | +0.88% | United States |
| 3 | AbbVieABBV | $434.8B | $246.04 | +0.89% | United States |
| 4 | Merck & Co.MRK | $317.6B | $128.58 | +0.16% | United States |
| 5 | NovartisNVS | $298.3B | $156.33 | +1.38% | Switzerland |
| 6 | AstrazenecaAZN | $250.3B | $161.42 | +0.22% | United Kingdom |
| 7 | Novo Nordisk A SNVO | $209.3B | $47.26 | +2.81% | Denmark |
| 8 | Abbott LaboratoriesABT | $186.6B | $107.81 | -0.14% | United States |
| 9 | PfizerPFE | $152.5B | $26.76 | +2.14% | United States |
| 10 | Bristol Myers SquibbBMY | $132.2B | $64.72 | +0.89% | United States |
| 11 | Vertex Pharmaceuticals Inc / MaVRTX | $125.7B | $496.07 | +2.49% | United States |
| 12 | GSKGSK | $107.3B | $52.96 | +1.51% | United Kingdom |
| 13 | SanofiSNY | $106.0B | $43.46 | +1.33% | France |
| 14 | Regeneron PharmaceuticalsREGN | $80.8B | $784.36 | +1.59% | United States |
| 15 | Takeda PharmaceuticalTAK | $55.1B | $17.45 | +2.53% | Japan |
| 16 | Teva Pharmaceutical IndustriesTEVA | $41.2B | $35.36 | +1.58% | Israel |
| 17 | BeOne MedicinesONC | $39.6B | $348.27 | +5.60% | Cayman Islands |
| 18 | Royalty PharmaRPRX | $32.6B | $56.77 | -0.86% | United States |
| 19 | ZoetisZTS | $30.5B | $72.66 | -5.97% | United States |
| 20 | Alnylam PharmaceuticalsALNY | $29.3B | $219.20 | +1.43% | United States |
| 21 | InsmedINSM | $28.4B | $131.10 | -1.09% | United States |
| 22 | Roivant SciencesROIV | $26.3B | $36.34 | +3.47% | United Kingdom |
| 23 | United TherapeuticsUTHR | $23.1B | $538.84 | +1.11% | United States |
| 24 | ViatrisVTRS | $19.1B | $16.43 | +0.86% | United States |
| 25 | Jazz PharmaceuticalsJAZZ | $16.7B | $256.56 | -0.04% | Ireland |
| 26 | BridgeBio PharmaBBIO | $16.5B | $84.48 | +2.03% | United States |
| 27 | Ascendis Pharma A/SASND | $15.8B | $255.41 | +2.23% | Denmark |
| 28 | Arrowhead PharmaceuticalsARWR | $12.4B | $87.65 | +2.12% | United States |
| 29 | Biomarin PharmaceuticalBMRN | $12.3B | $63.81 | +3.82% | United States |
| 30 | Corcept TherapeuticsCORT | $12.0B | $110.77 | +2.61% | United States |
| 31 | Madrigal PharmaceuticalsMDGL | $11.8B | $510.04 | -0.06% | United States |
| 32 | AbivaxABVX | $11.3B | $130.93 | +0.71% | France |
| 33 | Summit TherapeuticsSMMT | $11.1B | $13.96 | +3.10% | United States |
| 34 | Elanco Animal HealthELAN | $11.1B | $22.12 | -8.60% | United States |
| 35 | Axsome TherapeuticsAXSM | $10.9B | $212.74 | +1.24% | United States |
| 36 | Dr Reddys LaboratoriesRDY | $10.2B | $12.22 | +0.91% | India |
| 37 | Praxis Precision MedicinesPRAX | $10.1B | $360.76 | -2.54% | United States |
| 38 | CytokineticsCYTK | $9.55B | $76.76 | -5.67% | United States |
| 39 | Protagonist TherapeuticsPTGX | $9.44B | $145.87 | -0.21% | United States |
| 40 | Ionis PharmaceuticalsIONS | $9.40B | $56.56 | +3.80% | United States |
| 41 | Spyre TherapeuticsSYRE | $9.25B | $104.91 | +1.44% | United States |
| 42 | Crinetics PharmaceuticalsCRNX | $8.92B | $84.08 | +0.19% | United States |
| 43 | AlkermesALKS | $8.25B | $49.17 | +1.65% | Ireland |
| 44 | LiquidiaLQDA | $8.02B | $90.22 | +0.90% | United States |
| 45 | Rhythm PharmaceuticalsRYTM | $7.96B | $115.63 | +3.15% | United States |
| 46 | Tg TherapeuticsTGTX | $7.62B | $49.76 | +0.42% | United States |
| 47 | Cogent BiosciencesCOGT | $7.24B | $42.39 | +1.41% | United States |
| 48 | Mirum PharmaceuticalsMIRM | $6.54B | $100.65 | +6.94% | United States |
| 49 | Belite BioBLTE | $6.41B | $163.05 | +1.48% | United States |
| 50 | ErascaERAS | $6.30B | $18.41 | +0.77% | United States |
| 51 | Xenon PharmaceuticalsXENE | $6.12B | $63.36 | -1.84% | Canada |
| 52 | Ptc TherapeuticsPTCT | $6.12B | $73.31 | +3.47% | United States |
| 53 | Dianthus TherapeuticsDNTH | $6.09B | $108.92 | -0.91% | United States |
| 54 | Kiniksa Pharmaceuticals InternationalKNSA | $5.93B | $76.06 | -0.59% | United States |
| 55 | Ligand PharmaceuticalsLGND | $5.88B | $293.15 | -2.33% | United States |
| 56 | Amneal PharmaceuticalsAMRX | $5.79B | $18.14 | +0.39% | United States |
| 57 | Travere TherapeuticsTVTX | $5.78B | $61.32 | -1.81% | United States |
| 58 | GrifolsGRFS | $5.46B | $7.94 | +1.41% | Spain |
| 59 | Acadia PharmaceuticalsACAD | $5.03B | $29.21 | +2.67% | United States |
| 60 | Dyne TherapeuticsDYN | $4.90B | $26.25 | +1.43% | United States |
| 61 | Indivior PharmaceuticalsINDV | $4.84B | $38.82 | +0.39% | United Kingdom |
| 62 | VeradermicsMANE | $4.78B | $114.39 | +5.28% | United States |
| 63 | Edgewise TherapeuticsEWTX | $4.68B | $43.52 | -2.03% | United States |
| 64 | Enliven TherapeuticsELVN | $4.43B | $60.46 | +0.32% | United States |
| 65 | Parabilis MedicinesPBLS | $4.15B | $34.98 | -1.69% | United States |
| 66 | Genmab A/SGMAB | $4.01B | $31.25 | +4.76% | Denmark |
| 67 | Viking TherapeuticsVKTX | $4.00B | $34.26 | +2.88% | United States |
| 68 | Tango TherapeuticsTNGX | $3.92B | $27.07 | -6.65% | United States |
| 69 | Telix PharmaceuticalsTLX | $3.90B | $11.52 | +8.27% | Australia |
| 70 | Legend BiotechLEGN | $3.85B | $20.75 | +7.62% | United States |
| 71 | Structure TherapeuticsGPCR | $3.78B | $53.14 | +0.99% | United States |
| 72 | Aktis OncologyAKTS | $3.73B | $24.13 | +2.94% | United States |
| 73 | Arcus BiosciencesRCUS | $3.64B | $28.62 | +1.02% | United States |
| 74 | IDEAYA BiosciencesIDYA | $3.57B | $37.02 | +2.15% | United States |
| 75 | Organon & Co.OGN | $3.57B | $13.60 | +0.37% | United States |
| 76 | AlumisALMS | $3.52B | $27.60 | -0.72% | United States |
| 77 | NewAmsterdam PharmaNAMS | $3.34B | $27.96 | +1.05% | Netherlands |
| 78 | Vicore Pharma Holding ABVCRE | $3.33B | $11.83 | +0.00% | Sweden |
| 79 | MBX BiosciencesMBX | $3.23B | $67.82 | +1.06% | United States |
| 80 | uniQureQURE | $3.22B | $46.42 | +2.34% | Netherlands |
| 81 | Arcutis BiotherapeuticsARQT | $3.18B | $25.29 | -4.31% | United States |
| 82 | Disc MedicineIRON | $2.97B | $77.44 | +0.00% | United States |
| 83 | ImmunomeIMNM | $2.83B | $25.03 | -3.06% | United States |
| 84 | Supernus PharmaceuticalsSUPN | $2.77B | $47.64 | +1.88% | United States |
| 85 | AtaiBeckleyATAI | $2.67B | $7.25 | +0.97% | Germany |
| 86 | Nurix TherapeuticsNRIX | $2.65B | $25.53 | +1.23% | United States |
| 87 | Trevi TherapeuticsTRVI | $2.63B | $18.51 | +0.05% | United States |
| 88 | Zai LabZLAB | $2.62B | $23.32 | +11.69% | China |
| 89 | Prestige Consumer HealthcarePBH | $2.60B | $54.85 | +0.77% | United States |
| 90 | PrecigenPGEN | $2.59B | $7.23 | +4.63% | United States |
| 91 | Nektar TherapeuticsNKTR | $2.58B | $76.48 | +4.13% | United States |
| 92 | Ultragenyx PharmaceuticalRARE | $2.55B | $25.91 | +0.35% | United States |
| 93 | Amylyx PharmaceuticalsAMLX | $2.54B | $22.82 | -5.66% | United States |
| 94 | PharvarisPHVS | $2.43B | $34.91 | +1.33% | Netherlands |
| 95 | Viridian Therapeutics, Inc.\DEVRDN | $2.43B | $23.59 | +4.80% | United States |
| 96 | Kailera TherapeuticsKLRA | $2.42B | $18.66 | -1.11% | United States |
| 97 | Vera TherapeuticsVERA | $2.36B | $32.89 | +2.72% | United States |
| 98 | Bausch Health CompaniesBHC | $2.34B | $6.25 | +5.75% | Canada |
| 99 | Sionna TherapeuticsSION | $2.30B | $51.04 | +2.88% | United States |
| 100 | Nuvation BioNUVB | $2.30B | $6.60 | +8.02% | United States |
Showing the largest 100 of 501 companies. One row per company — secondary share classes are folded into their primary listing. Updated 9 Aug 2026.
Sectors biotechnology: pharmaceutical preparations companies sit in
Other industries
Semiconductors 100Computer Software: Programming Data Processing 77Computer Software: Prepackaged Software 232Computer Manufacturing 10Major Banks 245Industrial Machinery/Components 209Catalog/Specialty Distribution 30Business Services 93Commercial Banks 35Auto Manufacturing 29Integrated oil Companies 18Investment Bankers/Brokers/Service 68Real Estate Investment Trusts 179Department/Specialty Retail Stores 14Oil & Gas Production 116Telecommunications Equipment 82Beverages (Production/Distribution) 35Electronic Components 21Finance: Consumer Services 163Electric Utilities: Central 59Consumer Electronics/Appliances 23Natural Gas Distribution 29Medical Specialities 44Property-Casualty Insurers 68All industries →
Figures come from SEC filings and daily market prices. Companies listed only outside the US are not covered — see methodology.